Myeloma and leukaemia trials.

Myeloma and leukaemia trials.

Bibliográfalaš dieđut
Váldodahkki:	Peto, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1972

Geahča maid

Myeloma /
Dahkki: 455001 Tanner, Jerome E., et al.
Almmustuhtton: (2008)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
Dahkki: Eden, O, et al.
Almmustuhtton: (1991)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
Dahkki: Shah, V, et al.
Almmustuhtton: (2020)

Letter: Chemoimmunotherapy of adult acute leukaemia.
Dahkki: Peto, R, et al.
Almmustuhtton: (1975)

The adapted Zelen was a feasible design to trial exercise in myeloma survivors
Dahkki: Land, J, et al.
Almmustuhtton: (2020)

Protein profiling in myeloma in vivo; Effects of bortezomib in a mouse model of myeloma
Dahkki: Edwards, C, et al.
Almmustuhtton: (2007)

Myeloma cells isolated from patients with multiple myeloma express osteoprotegerin ligand.
Dahkki: Shipman, C, et al.
Almmustuhtton: (2000)

Animal models of multiple myeloma
Dahkki: Olechnowicz, SWZ, et al.
Almmustuhtton: (2019)

Myeloma kidney: improving clinical outcomes?
Dahkki: Haynes, R, et al.
Almmustuhtton: (2012)

Leukaemia.
Dahkki: Kinlen, L
Almmustuhtton: (1994)

IS THE INCIDENCE OF MULTIPLE-MYELOMA REALLY INCREASING
Dahkki: Velez, R, et al.
Almmustuhtton: (1981)

Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
Dahkki: Edwards, C, et al.
Almmustuhtton: (2007)

Bisphosphonates--mechanisms of action in multiple myeloma.
Dahkki: Shipman, C, et al.
Almmustuhtton: (2000)

Efek Antiproliferatif Pentagamavunon-O Terhadap Sel Myeloma: Atniproliferative Effect of Pentagamanunon-O on Myeloma Cells
Dahkki: Perpustakaan UGM, i-lib
Almmustuhtton: (2004)

Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council.
Dahkki: Cuckle, H, et al.
Almmustuhtton: (1979)

Myeloma-induced alloreactive T cells arising in Myeloma-infiltrated bones include double-positive CD8(+)CD4(+) T cells: evidence from myeloma-bearing mouse model
Dahkki: Freeman, L.M., et al.
Almmustuhtton: (2011)

Bone marrow adiposity and multiple myeloma
Dahkki: Morris, E, et al.
Almmustuhtton: (2018)

Advances in the management of myeloma bone disease.
Dahkki: Shipman, C, et al.
Almmustuhtton: (2005)

The pathogenesis of the bone disease of multiple myeloma.
Dahkki: Edwards, C, et al.
Almmustuhtton: (2008)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
Dahkki: Shipman, C, et al.
Almmustuhtton: (2000)

The Bone Marrow Microenvironment in Multiple Myeloma
Dahkki: Edwards, C
Almmustuhtton: (2010)

The role of BMP signalling in multiple myeloma
Dahkki: Gooding, S
Almmustuhtton: (2018)

Osteoprotegerin and the development of myeloma bone disease
Dahkki: Croucher, P, et al.
Almmustuhtton: (2004)

Sulforaphane - A new therapy for mutliple myeloma?
Dahkki: Locklin, R, et al.
Almmustuhtton: (2008)

Collaborative meta-analysis of randomised trials in chronic lymphocytic leukaemia (CLL)
Dahkki: Binet, J, et al.
Almmustuhtton: (1998)

Neonatal leukaemia
Dahkki: Roberts, I, et al.
Almmustuhtton: (2018)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
Dahkki: Chessells, J, et al.
Almmustuhtton: (1994)

Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients.
Dahkki: Group, M
Almmustuhtton: (2001)

Genomic patterns of progression in smoldering multiple myeloma
Dahkki: Bolli, N, et al.
Almmustuhtton: (2018)

Engineered nanomedicine for myeloma and bone microenvironment targeting
Dahkki: Swami, Archana, et al.
Almmustuhtton: (2015)

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: An overview of 6,633 patients from 27 randomized trials
Dahkki: Pasquali, S, et al.
Almmustuhtton: (1998)

Bracken spores and leukaemia.
Dahkki: Cook-Mozaffari, P, et al.
Almmustuhtton: (1990)

Host-derived MMP-7 decreases myeloma progression in vivo: An unexpected role for MMP-7 and osteopontin in myeloma pathogenesis
Dahkki: Lwin, S, et al.
Almmustuhtton: (2011)

Novel therapeutic targets in myeloma bone disease.
Dahkki: Webb, S, et al.
Almmustuhtton: (2014)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Dahkki: Croucher, P, et al.
Almmustuhtton: (2003)

Wnt signaling: bone's defense against myeloma.
Dahkki: Edwards, C
Almmustuhtton: (2008)

BTK inhibition in myeloma: targeting the seed and the soil.
Dahkki: Edwards, C
Almmustuhtton: (2012)

The role of host microenvironment in the pathogenesis of multiple myeloma
Dahkki: Lwin, STS
Almmustuhtton: (2014)

Testing novel therapies for the treatment of multiple myeloma
Dahkki: Tosun, C
Almmustuhtton: (2023)

Bisphosphonates and in vivo models of multiple myeloma - Reply
Dahkki: Shipman, C, et al.
Almmustuhtton: (2001)